LACTAMS AS INHIBITORS OF A-BETA PROTEIN PRODUCTION
申请人:Bristol-Myers Squibb Pharma Company
公开号:EP1267906A1
公开(公告)日:2003-01-02
[EN] LACTAMS AS INHIBITORS OF A-BETA PROTEIN PRODUCTION<br/>[FR] LACTAMES EN TANT QU'INHIBITEURS DE PRODUCTION DE PROTEINES A-BETA
申请人:DU PONT PHARM CO
公开号:WO2001072324A1
公开(公告)日:2001-10-04
This invention relates to novel lactams having the Formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome.